-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dpadrvh9Hhs+bPDr+6CDQQ8mAv71uuewYXCsfXbXXWBKu4f5MMt8SEK6O9Sqdg0p 9EvI7cgNdOPAiqo8PeKNSQ== 0000885725-06-000211.txt : 20061102 0000885725-06-000211.hdr.sgml : 20061102 20061102173055 ACCESSION NUMBER: 0000885725-06-000211 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20061031 FILED AS OF DATE: 20061102 DATE AS OF CHANGE: 20061102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kucheman William CENTRAL INDEX KEY: 0001379799 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 061183951 BUSINESS ADDRESS: BUSINESS PHONE: 508.650.8000 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760 3 1 kuc549.xml X0202 3 2006-10-31 0 0000885725 BOSTON SCIENTIFIC CORP (BSX) 0001379799 Kucheman William C/O BOSTON SCIENTIFIC CORPORATION ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760 0 1 0 0 SVP & Group President Common Stock 2844 D Common Stock 23471 I By 401(k) Deferred Stock Units Common Stock 21500 D Stock Option (Right to Buy) 14.16 2010-05-09 Common Stock 6000 D Stock Option (Right to Buy) 8.50 2010-07-25 Common Stock 6000 D Stock Option (Right to Buy) 6.13 2010-12-06 Common Stock 11668 D Stock Option (Right to Buy) 8.99 2011-07-17 Common Stock 25000 D Stock Option (Right to Buy) 12.50 2011-12-17 Common Stock 11000 D Stock Option (Right to Buy) 21.26 2012-12-09 Common Stock 32000 D Stock Option (Right to Buy) 34.79 2013-12-11 Common Stock 13000 D Stock Option (Right to Buy) 41.98 2014-06-15 Common Stock 100000 D Stock Option (Right to Buy) 34.29 2015-01-03 Common Stock 29233 D Stock Option (right to buy) 26.89 2015-07-01 Common Stock 49700 D Shares of common stock will be issued to the reporting person in five equal annual installments beginning on July 1, 2007, the second anniversary of the award, provided the reporting person continues to be an employee of Boston Scientific or in certain circumstances upon the reporting person's retirement from the Company. Each deferred stock unit represents the Company's promise to issue one share of Boston Scientific common stock. Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on May 9, 2001, 50% on May 9, 2002, 75% on May 9, 2003 and 100% on May 9, 2004, the anniversary date of the grant. Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on July 25, 2001, 50% on July 25, 2002, 75% on July 25, 2003 and 100% on July 25, 2004, the anniversary date of the grant. Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable in approximately equal annual increments on December 6, 2001, 2002 and 2003, the anniversary date of this grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock of the Company exercisable in equal annual increments on July 17, 2002, 2003, 2004 and 2005, the anniversary date of the grant. Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 17, 2002, 50% on December 17, 2003, 75% on December 17, 2004 and 100% on December 17, 2005, the anniversary date of the grant. Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable 25% on December 9, 2003, 50% on December 9, 2004, 75% on December 9, 2005 and 100% on December 9, 2006, the anniversary date of the grant. Grant to the reporting person of an option to purchase a specified number of shares exercisable in equal annual installments beginning on December 11, 2004, 2005, 2006 and 2007, the anniversary date of the grant. Grant to the reporting person of an option to buy a specified number of shares of Common Stock exercisable in equal annual increments on June 15, 2008, 2009 and 2010, the anniversary date of this grant. Grant to the reporting person of an option to buy a specified number of shares of common stock of the Company exercisable in equal annual installments on January 3, 2006, 2007, 2008 and 2009, the anniversary date of the grant. Grant to the reporting person of an option to buy a specified number of shares of common stock of the Company exercisable in equal annual installments on July 1, 2007, 2008, 2009, 2010 and 2011, the anniversary date of the grant. By: /s/ Lawrence J. Knopf, Attorney-in-fact 2006-11-02 EX-24 2 poakucheman.txt POWER OF ATTORNEY POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Paul W. Sandman, Lawrence J. Knopf and Kristin S.Caplice, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; (3) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of the Company, Forms 144 in accordance with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules and regulations thereunder; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of November, 2006. /s/ William Kucheman William Kucheman -----END PRIVACY-ENHANCED MESSAGE-----